Inflammatory bowel disease.

By E. Szigethy, L. McLafferty, A. Goyal. The Pediatric clinics of North America, 2011

6,524 citations recorded by the source corpus.

Subfields: Epidemiology, Genetics, Surgery

View Paper: https://www.semanticscholar.org/paper/2673f2ec5f4a08ea8249484625e6e04c215594c2

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. J. Tschopp
2. E. Latz
3. Katherine A. Fitzgerald
4. I. Zilber-Rosenberg
5. M. Lamkanfi
6. Julian Parkhill
7. Eugene Rosenberg
8. R. Medzhitov

In Genetics

1. Manuel A. González
2. I. Zilber-Rosenberg
3. J. Tschopp
4. M. Lamkanfi
5. Julian Parkhill
6. Bert Vogelstein
7. K. Boyd
8. Eugene Rosenberg

In Surgery

1. T. Kanneganti
2. I. Zilber-Rosenberg
3. Peter D. Siersema
4. J. Tschopp
5. M. Lamkanfi
6. Eugene Rosenberg
7. Q. Guan
8. R. Medzhitov

Citations in the corpus

• Pathomechanisms of Oxidative Stress in Inflammatory Bowel Disease and Potential Antioxidant Therapies (2017, background): “CD may occur in any region of the GI tract involving the ileum and colon in a discontinuous pattern by transmural inflammation, while UC affects only the colon and rectum continuously and is restricted to the mucosa [1].”
• Microbiota organization is a distinct feature of proximal colorectal cancers (2014, background): “Discussion Although it has been long suspected that bacteria contribute to chronic inflammation leading to CRC, to our knowledge this is the first time that bacterial biofilms, a known driver of tissue inflammation (3), have been identified in CRC.”
• Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome (2010, background): “INTRODUCTION Human inflammatory bowel disease (IBD), the most important entities being ulcerative colitis and Crohn’s disease, are chronic, relapsing and remitting inflammatory conditions that result from chronic dysregulation of the mucosal immune system in the gastrointestinal tract.(1) The precis”
• Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome (2019, background): “Throughout human history, the role of traditional Chinese herbal medicine (TCMs) as CAM in disease control and cure has been indispensable [199,200].”
• Bifidobacteria and Butyrate-Producing Colon Bacteria: Importance and Strategies for Their Stimulation in the Human Gut (2016, background): “prausnitzii A2-165 in rodents has shown attenuation of chemically induced colitis (Eeckhaut et al., 2013, 2014; Martín et al., 2015).”
• The Hologenome Concept: Human, Animal and Plant Microbiota (2014, background): “Cell, 124, 783–801. Allen, M. F. (1991). The ecology of mycorrhizae. Cambridge: Cambridge University Press. Amato, K. R., Yeoman, C. J., Kent, A., et al. (2013). Habitat degradation impacts black howler monkey (Alouatta pigra) gastrointestinal microbiomes.”
• NF-κB signaling in inflammation (2017, neutral): “94 The pathogenesis of IBD involves multiple cell types of the mucosal immune system, including intestinal epithelial cells, innate immune cells such as macrophages and neutrophils, T cells and innate lymphoid cells.”